


| Key | % Net Assets |
|---|---|
| 5.6% | |
| 4.6% | |
| 4.3% | |
| 4.2% | |
| 81.3% |
| Name | % Net Assets |
|---|---|
| Roche Holding AG | 5.6% |
| BG GROUP | 4.6% |
| EFG Eurobank Ergasias S.A. | 4.3% |
| ASML Holding N.V. | 4.2% |
| Lanxess AG | 3.8% |
| Key | % Net Assets |
|---|---|
| 16.70% | |
| 15.90% | |
| 15.30% | |
| 13.20% | |
| 12.80% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 7.01 |
| Currency | EUR |
| Change | 0.01 |
| % | 0.07% |
| YTD change | 0.45 |
| YTD % | 6.80% |
| Fund Inception | 12/07/2004 |
|---|---|
| Fund Manager | Phil Cliff |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 75000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.11 |
You are here: research